Omalizumab as a corticosteroid‐sparing agent in the treatment of bullous pemphigoid
Abstract Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease, characterized by the development of autoantibodies against hemidesmosomal components BP180 and BP230. The mainstay of therapy is topical and systemic corticosteroids (CS) and immunosuppressors. As this pathology...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2022-12-01
|
| Serier: | Dermatologic Therapy |
| Fag: | |
| Online adgang: | https://doi.org/10.1111/dth.15946 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|